| Title |
Cost Effectiveness of Anticoagulation in Acute Coronary Syndromes
|
|---|---|
| Published in |
PharmacoEconomics, October 2012
|
| DOI | 10.2165/11589290-000000000-00000 |
| Pubmed ID | |
| Authors |
Jaime Latour-Pérez, Eva de -Miguel-Balsa |
| Abstract |
The benefit of unfractionated heparin (UFH) added to aspirin in patients with acute coronary syndromes (ACS) was described more than 20 years ago. Ever since, a wide variety of anticoagulant drugs have become available for clinical use, including low-molecular-weight heparins (LMWH), direct thrombin inhibitors and selective factor Xa inhibitors. |
Mendeley readers
The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 2% |
| Chile | 1 | 2% |
| Unknown | 49 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 9 | 18% |
| Student > Ph. D. Student | 8 | 16% |
| Other | 5 | 10% |
| Researcher | 5 | 10% |
| Student > Bachelor | 5 | 10% |
| Other | 12 | 24% |
| Unknown | 7 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 23 | 45% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 8% |
| Economics, Econometrics and Finance | 3 | 6% |
| Nursing and Health Professions | 2 | 4% |
| Business, Management and Accounting | 2 | 4% |
| Other | 7 | 14% |
| Unknown | 10 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 November 2020.
All research outputs
#5,446,210
of 25,371,288 outputs
Outputs from PharmacoEconomics
#570
of 1,991 outputs
Outputs of similar age
#39,657
of 191,740 outputs
Outputs of similar age from PharmacoEconomics
#127
of 699 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,991 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,740 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 699 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.